[Vedolizumab in Crohn Disease genesis-sefh drug evaluation report]. [electronic resource]
- Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria Sep 2015
- 297-308 p. digital
Publication Type: Journal Article
2171-8695
10.7399/fh.2015.39.5.8981 doi
Antibodies, Monoclonal, Humanized--economics Crohn Disease--drug therapy Drug Evaluation Humans Immunosuppressive Agents--economics Multicenter Studies as Topic Randomized Controlled Trials as Topic